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Objective: To determine preoperative ventricular function in vascular amputees by
measuring N-terminal pro-brain natriuretic peptide (NT-proBNP) and to analyse the
relationship between NT-proBNP levels and 30-day postoperative mortality.
Design: Prospective pilot study.
Subjects and methods: In 19 patients planned for a lower limb amputation for non-
reconstructable peripheral arterial disease NT-proBNP was measured the day before
amputation.
Results: Four amputees died within 30 days after the amputation. In 17 of 19 patients
NT-proBNP values were found more than 2 standard deviations above the age cor-
rected reference value. Pre-amputation NT-proBNP levels did not differ significantly
between non-survivors and survivors (P¼ 0.162).
Conclusion: Preoperative NT-proBNP levels are not significantly related to 30-day
mortality after lower limb amputation procedure. Preoperative NT-proBNP levels are
very high, indicating that serious ventricular dysfunction may be present in vascular
amputees.
Introduction
Peri-operative mortality in lower limb amputees
is high.1 Myocardial infarction is the most
common cause of postoperative mortality.2
Cardiac function is relevant for the postamputa-
tion rehabilitation process because energy expen-
diture during gait is increased in lower limb
amputees.3–5 Thus regaining bipedal gait adds
an additional level of stress to the heart that
may already be compromised by pre-existing
heart disease. On the basis of the above
arguments one should pay attention to the pre-
sence of heart disease in vascular amputees to
prevent complications (mortality) not only
in the peri-operative phase but also in the
rehabilitation phase.
Recent literature has shown that plasma levels
of N-terminal pro-brain natriuretic peptide
(NT-proBNP) are elevated in patients with
asymptomatic left ventricular systolic dysfunction
and NT-proBNP levels are highly accurate for
detecting left ventricular failure.6 Elevated
NT-proBNP levels might also be a biomarker for
the early diagnosis of right ventricular systolic
dysfunction.7 Congestive heart failure patients
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with NT-proBNP values levels above median had
a one-year mortality of 53% compared with 11%
in patients with below-median levels of NT-
proBNP.8 In fact NT-proBNP was the strongest
independent predictor of one-year mortality in
patients with acute coronary syndrome.9
The aim of this study was to analyse the rela-
tionship between preoperative NT-proBNP levels
and 30-day mortality in lower limb amputees who
are amputated for a vascular disease.
Methods and materials
Nineteen consecutive patients undergoing a lower
limb amputation were studied; the amputations
were transtibial, transfemoral or through-knee.
Amputations were performed in the Vascular
Surgery Department at the Nij Smellinghe
Hospital in Drachten and University Medical
Centre Groningen. Patients were included if they
underwent the amputation for non-reconstructable
peripheral arterial disease. Demographics and
cardiac history were retrieved from the patient
charts.
EDTA-anticoagulated blood (10mL) was
collected by venous puncture the day before the
amputation. Blood samples were centrifuged
within 2 hours after sampling. Before storage at
80C 30 mL of an aprotinin solution (protease
inhibitor, 10 000 kIU/mL; Bayer, Germany) per
millilitre of plasma was added to the samples.
NT-proBNP (electrochemiluminescence immuno-
assay; Roche Diagnostics) was measured in the
week after collection.
Differences in levels of preoperative NT-
proBNP between patients who died in the 30-day
period after the amputation and patients who
survived that period were analysed using
Mann–Whitney test. Differences in levels of
preoperative NT-proBNP between the patients
with different amputations levels were analysed
using the Kruskal–Wallis test.
The preoperative NT-proBNP levels in non-
survivors and survivors were compared with the
reference values given by the manufacturer.
Results
Nineteen patients, 6 women and 13 men with a
mean age of 69.1 (SD 12.5) years, participated in
the study, 15 of whom had a history of cardiac
disease such as heart failure, valve disorder,
myocardial infarction and atrial fibrillation.
In total, five transfemoral, four through-knee
and 10 transtibial amputations were performed.
Four amputees died within 30 days after the
amputation. The median interquartile ranges
(IQR), mean values and standard deviations
of NT-proBNP are summarized in Table 1.
In general, levels of NT-proBNP were high. In
total 17 of 19 patients (89%) had NT-proBNP
value levels more than 2 SDs above the age-cor-
rected reference value. NT-proBNP levels were
higher in non-survivors than in survivors but the
difference was not significant. NT-proBNP levels
were highest in transfemoral amputees but this
difference was not significant (P¼ 0.248).
Table 1 NT-proBNP levels (ng/L) for the study population (n¼ 19) and for the different subgroups
Median IQR Mean SD P-value
NT-proBNP in total study group 3 723 428–6149 6 148 8 984
Survival 0.162*
Non-survivors (n¼ 4) 11 761 1612–3221 15 198 16 352
Survivors (n¼ 15) 2 471 417–5971 3 734 4 103
Level of amputation 0.248**
Transfemoral (n¼5) 5 971 2069–27 693 13 207 14 908
Through-knee (n¼4) 4 477 1909–5920 4 102 2 117
Transtibial (n¼ 10) 823 381–6388 3 437 4 842
NT-proBNP did not differ significantly between non-survivors and survivors and (30 days)* or between groups with different
amputation levels**.
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Discussion
NT-proBNP levels in the amputee non-survivor
group were very high compared with those of
survivors but the difference was not significant.
Preoperative NT-proBNP levels were not
associated with the level of amputation. Overall
NT-proBNP levels were high in 89% of the
vascular amputees, indicating that serious cardiac
disease may be present.
These high NT-proBNP levels may have clinical
importance because cardiac disease in vascular
amputees may be underdiagnosed in the preopera-
tive phase for several reasons. First, 25% of vas-
cular amputees have diabetes, which is associated
with a generalized hyposensitivity to pain.10
Therefore silent ischaemia may be a common
phenomenon in diabetic amputees with coronary
heart disease. Second, non-ambulant patients
with peripheral vascular disease fail to exhibit
symptoms of coronary disease because the pro-
gressive limb pain limits the ability to attain
levels of activity necessary to provoke symptoms
of cardiac ischaemia. In the pre-amputation
phase obviously most attention will be focused
on treatment of the life-threatening ischaemic
limb and concomitant heart disease may be
overlooked. In contrast, in the rehabilitation
phase cardiac problems may arise when the ampu-
tee starts walking with a prosthesis and the extra
energy necessary for walking with a prosthesis
cannot be provided by the compromised heart.3–5
NT-proBNP measurements in this study were
not significantly related to 30-day mortality. The
chosen follow-up of 30 days may be too short.
A longer follow-up of one year might show a
statistical significant relationship between pre-
operative NT-proBNP measurements and mortal-
ity in amputees.8,9 In these studies NT-proBNP
was an independent prognostic factor of one-
year mortality in a different population.8, 9
Because NT-proBNP levels are subject to intra-
individual variations these levels may not be
accurate enough as the only biomarker to evaluate
ventricular function adequately.11
The statistical power of this study is limited by
the small number of patients included. In a post-
hoc sample size calculation, the standard deviation
of the population in this study (8984) and the
difference in NT-proBNP between non-survivors
and survivors was used. This analysis resulted
in a total sample size of 22 patients: 11 in each
group. Our total sample was too small and the
distribution of non-survivors and survivors was
not optimal for statistical analysis. However, the
date of the current study can be used for sample
size calculation in future research focusing on
cardiac disease in vascular amputees.
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